Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Vaccine Synthesis and Formulation Processes

Thu, Oct 21, 2021 · 9:00 AM · Berlin
About This Webinar

Is your company currently looking to establish or increase vaccine manufacturing capacity? The race to meet demand for COVD-19 vaccines (and therapies) has dramatically reshaped the planning and execution of pharmaceutical manufacturing capital projects. And when it comes to vaccines, a proper understanding of the specific synthesis and formulation processes involved – and the current challenges therein – is essential for success. Without it, capital projects cannot be executed on time or budget in this highly challenging and dynamic environment.
In this fifth installment of the multi-part webinar series, we review the synthesis and formulation processes for the various vaccine types and do a deep-dive on subunit and subunit-conjugate vaccines. We outline the implications for any company currently looking to establish or increase manufacturing capacity for this vaccine platform.
Join our subject matter expert Christian Lavarreda on this fifth installment of "Vaccine Synthesis and Formulation Processes" on Thursday, October 21, 2021. This event will last approximately 45 minutes and include an interactive Q&A session.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Global Product Manager - Pure Media, Process, and Bioprocess Systems
Christian Lavarreda, based out of Dresden, Germany, is currently global product manager for pure media, process, and bioprocess systems at Syntegon. Formally trained as a chemical engineer, he is responsible for leading the development, commercialization, and marketing of Syntegon’s pharmaceutical liquid processing portfolio. Prior roles at Syntegon have also included regional business development and marketing manager for liquid pharmaceutical primary packaging in North America. During his four and a half years at Syntegon, Christian has utilized his expertise to connect customer needs to Syntegon’s capabilities while helping manage account relationships to ensure customer success and satisfaction. Christian also has a background in inhalable drug product development, where he spent twelve years leading R&D and commercialization activities of analytical instrumentation for the delivered-dose uniformity and particle size characterization of dry powder, metered-dose, nebulizer, and nasal inhalers. He has multiple peer-reviewed publications on the application of cascade impaction technology for the characterization of aerosolized medicines.
Hosted By
Syntegon Technology webinar platform hosts Vaccine Synthesis and Formulation Processes
Registered (62) View all
  • A4
  • M3
  • C4
  • I5
  • M2
  • P5
  • M3
  • D4
  • M1